Finance

SemBioSys Genetics reports Q3 2006 revenues of $123,039 compared to $682,678 a year ago

Published in Healthcare Finance, Tax and Law Weekly, December 6th, 2006

SemBioSys Genetics Inc. (SBS), a biotechnology company developing protein-based pharmaceuticals and nonpharmaceutical products, reported total revenues for the 3-month and 9-month periods ended September 30, 2006 were $123,039 and $390,570 respectively, compared with $682,678 and $1,731,092 for the corresponding periods in 2005.

Total revenue for the 3-month and 9-month periods ended September 30, 2006 consisted entirely of contract research compared with contract research revenue of $378,347 and $1,051,457 for the corresponding periods last year. The difference related to contract research is a result of the completion of collaboration agreements with Dow AgroSciences...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly

Source: Healthcare Finance, Tax and Law Weekly (2006-12-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry